| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |